Medical Aspects of Chemical Warfare (2008) - The Black Vault
Medical Aspects of Chemical Warfare (2008) - The Black Vault Medical Aspects of Chemical Warfare (2008) - The Black Vault
Medical Diagnosticsof deuterated TDG was passed through the same cartridges.The purified urine was mixed with concentratedhydrogen chloride (HCl) and heated. Sulfur mustardwas purged from the solution and trapped ontoa Tenax-TA adsorption tube. Analysis was performedusing a thermodesorption cold trap injector interfacedwith GC-MS. Analysis of urine samples obtained froma control group of patients found levels of TDG at lownanogram-to-milliliter concentrations. While mostof the control levels were approximately 5 ng/mL,two individuals had levels that exceeded 20 ng/mL.These high background levels probably indicate thatthe method was also converting another analyte, inaddition to TDG, into sulfur mustard (see below).Table 22-6reports published prior to 1995 showing laboratory analysis of humanbiomedical samples following suspected exposure to sulfur mustardPatient Sample Information* Unmetabolized Sulfur Mustard Hydrolysis Product †Urine samples from 2 Iran-Iraq War casualties Patient 1: 1.0 ng/ml nmtreated at Vienna hospital; collected 7 days after Patient 2: 1.5 ng/mLincident (no date given) 1Urine samples from 5 Iranian casualties treated at nm patient C1: 90 ng/mLGhent hospital; collectedpatient C2: 45 ng/mL10 days after incident (March 9, 1984) 2 patient C3: 40 ng/mLpatient C4: 40 ng/mLpatient C5: 15 ng/mLcontrol samples: 3–55 ng/mLUrine samples from 5 Iranian casualties treated at nm patient range: 3–140 ng/mLUtrecht hospital; collected 10 days after incident C control samples: 3–55 ng/mL(March 9, 1984) 2Hair samples from 2 Iranian casualties; collected 1 Patient 1: 0.5–1.0 µg/gram nmday after incident (Feb 27, 1986) 3patient 2: not detectedAutopsy specimens (tissues and body fluids) Urine: not detected; Fat, Skin, Brain, NMfrom Iranian casualty treated at MunichKidney: 5–15 mg/kg; Muscle, Liver,hospital; collected 7 days after incident (1985) 4 Spleen, Lung: 1–2 mg/kgUrine samples from 12 Iran-Iraq War casualties 1–30 ng/mL for 6 individuals; not NM(1986); no other details provided 5 detected in 6 individualsUrine samples from 7 Iranian casualties treated at NM 5–6 days postexposure:Ghent hospital; collected 5–6 and 18–19 daysrange 7–336 ng/mL;after incident (Feb 12–13, 1986) 618–19 days postexposure:range 3–7 ng/mLUrine samples from 3 Iranian casualties treated at nm patient range: 4–8 ng/mLGhent hospital; collected 18–19 days after C control samples: 1–21 ng/mLincident (Feb 12–13, 1986) 6Urine samples from 8 Iranian casualties treated at nm patient range: 5–76 ng/mLUtrecht hospital; collected 8–9 days after C control samples: 1–21 ng/mLincident (Feb 12–13, 1986) 6*These are the known details of the incident and sample collection time after suspected exposure.† The hydrolysis product was thiodiglycol.NM: not measuredData sources: (1) Vycudilik W. Detection of mustard gas bis(2-chloroethyl)-sulfide in urine. Forensic Sci Int. 1985;28:131–136. (2) Wils ERJ,Hulst AG, de Jong AL, Verweij A, Boter HL. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas. J AnalToxicol. 1985;9:254–257. (3) United Nations Security Council. Report of the mission dispatched by the Secretary-General to investigate allegationsof the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. New York, NY: UN; 1986. Report S/17911. (4) DraschG, Kretschmer E, Kauert G, von Meyer L. Concentrations of mustard gas [bis(2-chloroethyl)sulfide] in the tissues of a victim of a vesicantexposure. J Forensic Sci. 1987;32:1788–1793. (5) Vycudilik W. Detection of bis(2-chloroethyl)-sulfide (Yperite) in urine by high resolution gaschromatography-mass spectrometry. Forensic Sci Int. 1987;35:67–71. (6) Wils ERJ, Hulst AG, van Laar J. Analysis of thiodiglycol in urine ofvictims of an alleged attack with mustard gas, part II. J Anal Toxicol. 1988;12:15–19.709
Medical Aspects of Chemical WarfareDrasch et al examined urine samples for unmetabolizedsulfur mustard. Following organic extraction,thin-layer chromatography, and derivativation withgold, the extracts were analyzed using electrothermalatomic absorption spectroscopy. 85More recently, additional methods have beendeveloped for trace level analysis of TDG and TDGsulfoxidein urine. 86–89 There are a number of characteristicscommon to the methods (Table 22-7). They alluse GC in association with some form of MS analysis,use a derivatizing agent to make the analyte moreamenable to GC analysis and to increase sensitivity,and incorporate an isotopically labeled form of TDGas an internal standard. Most of the methods use asolid phase extraction cartridge for sample preparation.Some of the methods incubate the urine sampleswith glucuronidase with sulfatase activity to releaseany glucuronide-bound conjugates. Some of the methodsuse titanium trichloride in hydrochloric acid toreduce TDG-sulfoxide to TDG. The strong acid alsohydrolyzes acid-labile esters of TDG and TDG-sulfoxide(Table 22-8). Ultimately, each of the methodsconverts all target analytes into the single analyte TDGfor analysis. All of the methods have similar limits ofdetection, approximately 0.5 to 1 ng/mL. Although anassay has been developed to analyze TDG-sulfoxideseparately without a conversion to TDG, the methodis complicated by the high polarity of the analyte. 90Consequently, the more common approach is to usethe reducing agent titanium trichloride.Unfortunately, regardless of the analytical methodused, background levels have consistently been foundin urine samples obtained from nonexposed individuals.In the most extensive study of background levels,urine samples from 105 individuals were examinedfor sulfur mustard metabolites using an assay thatincorporates both a deconjugation process and a reductionstep (ie, the assay measures free and boundforms of both TDG and of TDG-sulfoxide). 89 Quantifiablebackground levels were observed in 82% of thesamples. Nearly 60% of the samples had observedlevels of TDG in the 0.5- to 2.0-ng/mL range, whileapproximately 9% had levels in the 10- to 20-ng/mLrange. When urine samples with higher backgroundTable 22-7Analysis Methods for Urine Samples to Measure Thiodiglycol or Thiodiglycoland Thiodiglycol-SulfoxideGlucuronidase TiCl 3Internal DetectionInstrumentation Derivativizing Agent SPE Cartridge Incubation Reduction Standard LimitNegative ion chemical Pentafluorobenzoyl Florisil Yes no 2H 4-TDG ~ 1 ng/mL 1ionization GC-MS chlorideElectron impact GC-MS Heptafluorobutyric None Yes no 2 H 8-TDG ~ 1 ng/mL 2anhydrideNegative ion chemical Pentafluorobenzoyl Florisil No yes 2 H 4-TDG < 1 ng/mL 3ionization GC-MS-MS chloridePositive chemical ioni- Heptafluorobutyric Oasis HLB Yes yes13C 4-TDG 0.5 ng/mL 4zation GC-MS-MS anhydride13 C 4: isotopically labeled carbon2 H 4: isotopically labeled hydrogen or deuterium2 H 8: isotopically labeled hydrogen or deuteriumGC: gas chromatographyHLB: hydrophilic-lipophilic-balancedMS: mass spectrometrySPE: solid phase extractionTDG: thiodiglycolTiCl 3: titanium trichlorideData sources: (1) Black RM, Read RW. Detection of trace levels of thiodiglycol in blood, plasma and urine using gas chromatography-electroncapturenegative-ion chemical ionisation mass spectrometry. J Chromatogr. 1988;449:261–270. (2) Jakubowski EM, Woodard CL, MershonMM, Dolzine TW. Quantification of thiodiglycol in urine by electron ionization gas chromatography-mass spectrometry. J Chromatogr.1990;528:184–190. (3) Black RM, Read RW. Improved methodology for the detection and quantitation of urinary metabolites of sulphurmustard using gas chromatography-tandem mass spectrometry. J Chromatogr B Biomed Appl. 1995;665:97–105. (4) Boyer AE, Ash D, Barr DB,et al. Quantitation of the sulfur mustard metabolites 1,1’-sulfonylbis[2-(methylthio)ethane] and thiodiglycol in urine using isotope-dilutiongas chromatography-tandem mass spectrometry. J Anal Toxicol. 2004;28:327–332.710
- Page 681 and 682: Medical Aspects of Chemical Warfare
- Page 683 and 684: Medical Aspects of Chemical Warfare
- Page 685 and 686: Medical Aspects of Chemical Warfare
- Page 687 and 688: Medical Aspects of Chemical Warfare
- Page 689 and 690: Medical Aspects of Chemical Warfare
- Page 691 and 692: Medical Aspects of Chemical Warfare
- Page 693 and 694: Medical Aspects of Chemical Warfare
- Page 695 and 696: Medical Aspects of Chemical Warfare
- Page 697 and 698: Medical Aspects of Chemical Warfare
- Page 699 and 700: Medical Aspects of Chemical Warfare
- Page 701 and 702: Medical Aspects of Chemical Warfare
- Page 703 and 704: Medical Aspects of Chemical Warfare
- Page 705 and 706: Medical Aspects of Chemical Warfare
- Page 707 and 708: Medical Aspects of Chemical Warfare
- Page 709 and 710: Medical Aspects of Chemical Warfare
- Page 711 and 712: Medical Aspects of Chemical Warfare
- Page 713 and 714: Medical Aspects of Chemical Warfare
- Page 715 and 716: Medical Aspects of Chemical Warfare
- Page 717 and 718: Medical Aspects of Chemical Warfare
- Page 719 and 720: Medical Aspects of Chemical Warfare
- Page 721 and 722: Medical Aspects of Chemical Warfare
- Page 723 and 724: Medical Aspects of Chemical Warfare
- Page 725 and 726: Medical Aspects of Chemical Warfare
- Page 727 and 728: Medical Aspects of Chemical Warfare
- Page 729 and 730: Medical Aspects of Chemical Warfare
- Page 731: Medical Aspects of Chemical Warfare
- Page 735 and 736: Medical Aspects of Chemical Warfare
- Page 737 and 738: Medical Aspects of Chemical Warfare
- Page 739 and 740: Medical Aspects of Chemical Warfare
- Page 741 and 742: Medical Aspects of Chemical Warfare
- Page 743 and 744: Medical Aspects of Chemical Warfare
- Page 745 and 746: Medical Aspects of Chemical Warfare
- Page 747 and 748: • Analyze using GC-MS with methan
- Page 749 and 750: Medical Aspects of Chemical Warfare
- Page 751 and 752: Medical Aspects of Chemical Warfare
- Page 753 and 754: Medical Aspects of Chemical Warfare
- Page 755 and 756: Medical Aspects of Chemical Warfare
- Page 757 and 758: Medical Aspects of Chemical Warfare
- Page 759 and 760: Medical Aspects of Chemical Warfare
- Page 761 and 762: Medical Aspects of Chemical Warfare
- Page 763 and 764: Medical Aspects of Chemical Warfare
- Page 765 and 766: Medical Aspects of Chemical Warfare
- Page 767 and 768: Medical Aspects of Chemical Warfare
- Page 769 and 770: Medical Aspects of Chemical Warfare
- Page 771 and 772: Medical Aspects of Chemical Warfare
- Page 773 and 774: Medical Aspects of Chemical Warfare
- Page 775 and 776: Medical Aspects of Chemical Warfare
- Page 777 and 778: Medical Aspects of Chemical Warfare
- Page 779 and 780: Medical Aspects of Chemical Warfare
- Page 781 and 782: Medical Aspects of Chemical Warfare
<strong>Medical</strong> <strong>Aspects</strong> <strong>of</strong> <strong>Chemical</strong> <strong>Warfare</strong>Drasch et al examined urine samples for unmetabolizedsulfur mustard. Following organic extraction,thin-layer chromatography, and derivativation withgold, the extracts were analyzed using electrothermalatomic absorption spectroscopy. 85More recently, additional methods have beendeveloped for trace level analysis <strong>of</strong> TDG and TDGsulfoxidein urine. 86–89 <strong>The</strong>re are a number <strong>of</strong> characteristicscommon to the methods (Table 22-7). <strong>The</strong>y alluse GC in association with some form <strong>of</strong> MS analysis,use a derivatizing agent to make the analyte moreamenable to GC analysis and to increase sensitivity,and incorporate an isotopically labeled form <strong>of</strong> TDGas an internal standard. Most <strong>of</strong> the methods use asolid phase extraction cartridge for sample preparation.Some <strong>of</strong> the methods incubate the urine sampleswith glucuronidase with sulfatase activity to releaseany glucuronide-bound conjugates. Some <strong>of</strong> the methodsuse titanium trichloride in hydrochloric acid toreduce TDG-sulfoxide to TDG. <strong>The</strong> strong acid alsohydrolyzes acid-labile esters <strong>of</strong> TDG and TDG-sulfoxide(Table 22-8). Ultimately, each <strong>of</strong> the methodsconverts all target analytes into the single analyte TDGfor analysis. All <strong>of</strong> the methods have similar limits <strong>of</strong>detection, approximately 0.5 to 1 ng/mL. Although anassay has been developed to analyze TDG-sulfoxideseparately without a conversion to TDG, the methodis complicated by the high polarity <strong>of</strong> the analyte. 90Consequently, the more common approach is to usethe reducing agent titanium trichloride.Unfortunately, regardless <strong>of</strong> the analytical methodused, background levels have consistently been foundin urine samples obtained from nonexposed individuals.In the most extensive study <strong>of</strong> background levels,urine samples from 105 individuals were examinedfor sulfur mustard metabolites using an assay thatincorporates both a deconjugation process and a reductionstep (ie, the assay measures free and boundforms <strong>of</strong> both TDG and <strong>of</strong> TDG-sulfoxide). 89 Quantifiablebackground levels were observed in 82% <strong>of</strong> thesamples. Nearly 60% <strong>of</strong> the samples had observedlevels <strong>of</strong> TDG in the 0.5- to 2.0-ng/mL range, whileapproximately 9% had levels in the 10- to 20-ng/mLrange. When urine samples with higher backgroundTable 22-7Analysis Methods for Urine Samples to Measure Thiodiglycol or Thiodiglycoland Thiodiglycol-SulfoxideGlucuronidase TiCl 3Internal DetectionInstrumentation Derivativizing Agent SPE Cartridge Incubation Reduction Standard LimitNegative ion chemical Pentafluorobenzoyl Florisil Yes no 2H 4-TDG ~ 1 ng/mL 1ionization GC-MS chlorideElectron impact GC-MS Heptafluorobutyric None Yes no 2 H 8-TDG ~ 1 ng/mL 2anhydrideNegative ion chemical Pentafluorobenzoyl Florisil No yes 2 H 4-TDG < 1 ng/mL 3ionization GC-MS-MS chloridePositive chemical ioni- Heptafluorobutyric Oasis HLB Yes yes13C 4-TDG 0.5 ng/mL 4zation GC-MS-MS anhydride13 C 4: isotopically labeled carbon2 H 4: isotopically labeled hydrogen or deuterium2 H 8: isotopically labeled hydrogen or deuteriumGC: gas chromatographyHLB: hydrophilic-lipophilic-balancedMS: mass spectrometrySPE: solid phase extractionTDG: thiodiglycolTiCl 3: titanium trichlorideData sources: (1) <strong>Black</strong> RM, Read RW. Detection <strong>of</strong> trace levels <strong>of</strong> thiodiglycol in blood, plasma and urine using gas chromatography-electroncapturenegative-ion chemical ionisation mass spectrometry. J Chromatogr. 1988;449:261–270. (2) Jakubowski EM, Woodard CL, MershonMM, Dolzine TW. Quantification <strong>of</strong> thiodiglycol in urine by electron ionization gas chromatography-mass spectrometry. J Chromatogr.1990;528:184–190. (3) <strong>Black</strong> RM, Read RW. Improved methodology for the detection and quantitation <strong>of</strong> urinary metabolites <strong>of</strong> sulphurmustard using gas chromatography-tandem mass spectrometry. J Chromatogr B Biomed Appl. 1995;665:97–105. (4) Boyer AE, Ash D, Barr DB,et al. Quantitation <strong>of</strong> the sulfur mustard metabolites 1,1’-sulfonylbis[2-(methylthio)ethane] and thiodiglycol in urine using isotope-dilutiongas chromatography-tandem mass spectrometry. J Anal Toxicol. 2004;28:327–332.710